CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823523180
- Phone
- 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice
- 4 Insider Changes in Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 5 of 23 · 453 filings